Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Olmesartan medoxomil
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Olmesartan medoxomil 20mg tablets
0205052B0AAABAB
|
Olmesartan medoxomil | Olmesartan medoxomil | Cardiovascular System | 42,867 |
|
Olmesartan medoxomil 10mg tablets
0205052B0AAAAAA
|
Olmesartan medoxomil | Olmesartan medoxomil | Cardiovascular System | 33,320 |
|
Olmesartan medoxomil 40mg tablets
0205052B0AAACAC
|
Olmesartan medoxomil | Olmesartan medoxomil | Cardiovascular System | 29,162 |
|
Olmetec 20mg tablets
0205052B0BBABAB
|
Olmetec | Olmesartan medoxomil | Cardiovascular System | 1,184 |
|
Olmetec 10mg tablets
0205052B0BBAAAA
|
Olmetec | Olmesartan medoxomil | Cardiovascular System | 1,087 |
|
Olmetec 40mg tablets
0205052B0BBACAC
|
Olmetec | Olmesartan medoxomil | Cardiovascular System | 513 |
|
Olmesartan medoxomil 10mg/5ml oral liquid
0205052B0AAADAD
|
Olmesartan medoxomil | Olmesartan medoxomil | Cardiovascular System | 3 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.